News

News

PublISHED ON 11 October 2018

UpDATED ON 23 November 2018

Research funding available for next-generation biologics

The Swedish Research Council and Vinnova have formulated a national programme for protein research, method development and production of biologics. It is now possible to apply for up to 10 million SEK for protein research and process development for biologics. The call closes January 15, 2019. 

The programme is a part of the government’s strategic investment in life science aiming to promote better health, face societal challenges, strengthen Sweden’s position as a leading country for research and development, and increase Sweden’s competitiveness in an international perspective.

The programme contains both protein research for biologics, as well as development of more efficient methods for next-generation production of biologics. The programme runs from 2016 to 2023 and comprises 320 million SEK in total.

A call for protein research and process development for biologics is now open and closes January 15, 2019.

You can find all the information (in Swedish) about the call on Vinnova’s websiteexternal link.

PUBLISHED ON 11 October 2018

UpDATED ON 23 November 2018

Pdf / Printout


MORE WITHIN THE SAME SUBJECT AREA

  1. 10 million SEK to national study of COVID-19

    The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by CO...

  2. 10 million SEK to Biobank Sweden for coordinating COVID-19 samples

    Biobank Sweden will receive 10 million SEK from the Swedish Research Council to coordinate the collection of and access to samples linked to COVID-19. This will not only make the process easier for researchers, but also for patients and society as a ...

  3. Madeleine Durbeej-Hjalt appointed Secretary General for Medicine and Health

    She is a professor of muscle biology and a great advocate for basic researcher-initiated research. But Madeleine Durbeej-Hjalt thinks that one of the most important tasks right now is to consider the ongoing pandemic and its consequences.